Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique

Clinical Biochemistry

Volumn 41, Issue 10-11, 2008, Pages 910-913

  Ansermot, Nicolas ^a   Fathi, Marc ^a   Veuthey, Jean Luc ^b   Desmeules, Jules ^a   Rudaz, Serge ^b   Hochstrasser, Denis ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bland Altman; EMIT; Immunosuppressants; LC MS; Method comparison; Passing Bablok

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ARTICLE; DRUG BLOOD LEVEL; ELECTROSPRAY MASS SPECTROMETRY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GRAFT RECIPIENT; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS; VALIDATION STUDY;

CROSS REACTIONS; CYCLOSPORINE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HUMANS; IMMUNOASSAY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY;

EID: 44949129603     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.02.015     Document Type: Article

References (33)

1. Kaufman D.B., Shapiro R., Lucey M.R., Cherikh W.S., Bustami R.T., and Dyke D.B. Immunosuppression: practice and trends. Am J Transplant 4 Suppl 9 (2004) 38-53
2. Taylor A.L., Watson C.J., and Bradley J.A. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 56 (2005) 23-46
3. Kahan B.D., Keown P., Levy G.A., and Johnston A. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. Clin Ther 24 (2002) 330-350
4. Lemaire M., and Tillement J.P. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood. J Pharm Pharmacol 34 (1982) 715-718
5. Nagase K., Iwasaki K., Nozaki K., and Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol 46 (1994) 113-117
6. Andrews D.J., and Cramb R. Cyclosporin: revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem 39 (2002) 424-435
7. Wallemacq P.E. Therapeutic monitoring of immunosuppressant drugs. Where are we?. Clin Chem Lab Med 42 (2004) 1204-1211
8. Schutz E., Svinarov D., Shipkova M., Niedmann P.D., Armstrong V.W., Wieland E., et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem 44 (1998) 2158-2164
9. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific?. Clin Chem 45 (1999) 371-381
10. Hamwi A., Veitl M., Manner G., Ruzicka K., Schweiger C., and Szekeres T. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations. Am J Clin Pathol 112 (1999) 358-365
11. Salm P., Rutherford D.M., Taylor P.J., Black M.J., and Pillans P.I. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients. Clin Biochem 33 (2000) 557-562
12. Staatz C.E., Taylor P.J., and Tett S.E. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients. Ther Drug Monit 24 (2002) 607-615
13. Boer K., Deufel T., Schmidt D., Streck S., and Kiehntopf M. Application of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 high volume clinical chemistry analyzer. Clin Biochem 39 (2006) 1041-1043
14. Ansermot N., Fathi M., Veuthey J.-L., Desmeules J., Rudaz S., and Hochstrasser D. Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem (2008) 10.1016/j.clinbiochem.2008.02.014
15. Passing H. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21 (1983) 709-720
16. Passing H., and Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J Clin Chem Clin Biochem 22 (1984) 431-445
17. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
18. Bland J.M., and Altman D.G. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 346 (1995) 1085-1087
19. Stockl D., Dewitte K., and Thienpont L.M. Validity of linear regression in method comparison studies: is it limited by the statistical model or the quality of the analytical input data?. Clin Chem 44 (1998) 2340-2346
20. Martin R.F. General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 46 (2000) 100-104
21. Dewitte K., Fierens C., Stockl D., and Thienpont L.M. Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin Chem 48 (2002) 799-801
22. Johnston A., Chusney G., Schutz E., Oellerich M., Lee T.D., and Holt D.W. Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose (C2). Ther Drug Monit 25 (2003) 167-173
23. Cattaneo D., Zenoni S., Murgia S., Merlini S., Baldelli S., Perico N., et al. Comparison of different cyclosporine immunoassays to monitor C0 and C2 blood levels from kidney transplant recipients: not simply overestimation. Clin Chim Acta 355 (2005) 153-164
24. LeGatt D.F., Shalapay C.E., and Cheng S.B. The EMIT 2000 tacrolimus assay: an application protocol for the Beckman Synchron LX20 PRO analyzer. Clin Biochem 37 (2004) 1022-1030
25. Dunn C.J., Wagstaff A.J., Perry C.M., Plosker G.L., and Goa K.L. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation. Drugs 61 (2001) 1957-2016
26. Yatscoff R.W., Rosano T.G., and Bowers L.D. The clinical significance of cyclosporine metabolites. Clin Biochem 24 (1991) 23-35
27. Gonschior A.K., Christians U., Winkler M., Linck A., Baumann J., and Sewing K.F. Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients. Clin Chem 42 (1996) 1426-1432
28. Iwasaki K., Shiraga T., Matsuda H., Nagase K., Tokuma Y., Hata T., et al. Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. Drug Metab Dispos 23 (1995) 28-34
29. Bleck J.S., Schlitt H.J., Christians U., Schottmann R., Thiesemann C., Strohmeyer S., et al. Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function. Eur J Clin Pharmacol 40 (1991) 565-569
30. Winkler M., Schumann G., Petersen D., Oellerich M., and Wonigeit K. Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporine in whole blood after kidney, heart, and liver transplantation. Clin Chem 38 (1992) 123-126
31. Oellerich M., Armstrong V.W., Kahan B., Shaw L., Holt D.W., Yatscoff R., et al. Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 17 (1995) 642-654
32. Jusko W.J., Thomson A.W., Fung J., McMaster P., Wong S.H., Zylber-Katz E., et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 17 (1995) 606-614
33. Oellerich M., Armstrong V.W., Schutz E., and Shaw L.M. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem 31 (1998) 309-316